Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
April 22, 2026
April 22, 2026
NEW YORK, April 22 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
*
NEW YORK, April 22, 2026 -Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's dec . . .
* * *
Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
*
NEW YORK, April 22, 2026 -Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's dec . . .
